Travere Therapeutics (TVTX) PT Raised to $43 at Stifel

April 14, 2026 3:07 PM

Stifel analyst Alex Thompson raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $43.00 (from $31.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found